Skip to content

Clinical trials

Observational Heart Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Observational Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20143
20151
20171
20181
20191
20222
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Active, not recruiting2
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ablacon, Inc.1
Alexion Pharmaceuticals, Inc.1
Boston Scientific Corporation1
Catharina Ziekenhuis Eindhoven1
ECRI bv1
Erasmus Medical Center1
European Cardiovascular Research Center1
Hospital Clinic of Barcelona1
Idoven 1903 S.L.1
Institut für Pharmakologie und Präventive Medizin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases14
Cardiovascular Diseases6
Arrhythmias, Cardiac4
Atrial Fibrillation3
Cardiomyopathies3
Heart Failure2
Myocardial Infarction2
Myocardial Ischemia2
Acute Coronary Syndrome1
Aortic Valve Stenosis1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.